Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1236779

Recent Advances in Radiotherapy Modalities for Prostate Cancer


Murgić, Jure; Fröbe, Ana; Kiang Chua, Melvin Lee
Recent Advances in Radiotherapy Modalities for Prostate Cancer // Acta clinica Croatica, 61 (2022), Supplement 3; 57-63 doi:10.20471/acc.2022.61.s3.8 (domaća recenzija, članak, znanstveni)


CROSBI ID: 1236779 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Recent Advances in Radiotherapy Modalities for Prostate Cancer

Autori
Murgić, Jure ; Fröbe, Ana ; Kiang Chua, Melvin Lee

Izvornik
Acta clinica Croatica (0353-9466) 61 (2022), Supplement 3; 57-63

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
prostate cancer ; radiotherapy ; hypofractionation ; stereotactic body radiotherapy ; dose escalation ; clinical trials

Sažetak
Radiotherapy is the attractive treatment option for prostate cancer and has a clear role in all stages of the disease. Over the last decade, advances in technology, imaging capabilities, and improved radiobiological understanding have deeply transformed radiotherapy for prostate cancer, allowing dose escalation and wide adoption of hypofractionation. Furthermore, the integration of magnetic resonance imaging (MRI) and improved physical precision of dose delivery have given an impetus to additionally target intraprostatic tumor lesions, previously agnostic to conventional radiotherapy target definition concept. The emerging data from randomized clinical trials and observation research show that ultra- hypofractionation is a safe approach while further follow-up is needed to assess its efficacy compared to standard fractionation. There is an ongoing uncertainty surrounding true alpha/beta ratio for prostate cancer since hypofractionation has so far failed to yield theoretically envisioned superior biochemical control outcomes. Finally, recently published randomized trial settled ongoing controversy regarding the role of elective pelvic lymph node radiotherapy in patients with high-risk prostate cancer, showing clear benefit when pelvic nodes were treated to 50 Gy. The role of partial gland dose escalation/tumor boosting is evolving, and more data is needed to adopt this approach in routine clinical care. Going forward, molecular imaging will be crucial to assess biology of the disease, predict a response potentially, and optimally personalize radiotherapy treatment decisions. In this narrative review, we critically analyzed the published literature and provided practical summary of recent prostate radiotherapy advances for busy clinicians.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Stomatološki fakultet, Zagreb,
KBC "Sestre Milosrdnice"

Profili:

Avatar Url Ana Fröbe (autor)

Avatar Url Jure Murgić (autor)

Poveznice na cjeloviti tekst rada:

doi hrcak.srce.hr

Citiraj ovu publikaciju:

Murgić, Jure; Fröbe, Ana; Kiang Chua, Melvin Lee
Recent Advances in Radiotherapy Modalities for Prostate Cancer // Acta clinica Croatica, 61 (2022), Supplement 3; 57-63 doi:10.20471/acc.2022.61.s3.8 (domaća recenzija, članak, znanstveni)
Murgić, J., Fröbe, A. & Kiang Chua, M. (2022) Recent Advances in Radiotherapy Modalities for Prostate Cancer. Acta clinica Croatica, 61 (Supplement 3), 57-63 doi:10.20471/acc.2022.61.s3.8.
@article{article, author = {Murgi\'{c}, Jure and Fr\"{o}be, Ana and Kiang Chua, Melvin Lee}, year = {2022}, pages = {57-63}, DOI = {10.20471/acc.2022.61.s3.8}, keywords = {prostate cancer, radiotherapy, hypofractionation, stereotactic body radiotherapy, dose escalation, clinical trials}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2022.61.s3.8}, volume = {61}, number = {Supplement 3}, issn = {0353-9466}, title = {Recent Advances in Radiotherapy Modalities for Prostate Cancer}, keyword = {prostate cancer, radiotherapy, hypofractionation, stereotactic body radiotherapy, dose escalation, clinical trials} }
@article{article, author = {Murgi\'{c}, Jure and Fr\"{o}be, Ana and Kiang Chua, Melvin Lee}, year = {2022}, pages = {57-63}, DOI = {10.20471/acc.2022.61.s3.8}, keywords = {prostate cancer, radiotherapy, hypofractionation, stereotactic body radiotherapy, dose escalation, clinical trials}, journal = {Acta clinica Croatica}, doi = {10.20471/acc.2022.61.s3.8}, volume = {61}, number = {Supplement 3}, issn = {0353-9466}, title = {Recent Advances in Radiotherapy Modalities for Prostate Cancer}, keyword = {prostate cancer, radiotherapy, hypofractionation, stereotactic body radiotherapy, dose escalation, clinical trials} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font